171 – 180 of 257
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: Part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN
(
- Contribution to journal › Scientific review
-
Mark
Allergy: a systemic disease? The HUNT and Young-HUNT study, Norway.
(
- Contribution to journal › Article
-
Mark
Discovery of a potent and long-acting bronchorelaxing capsazepinoid, RESPIR 4-95
(
- Contribution to journal › Article
-
Mark
Asthmatic symptoms among pupils in relation to microbial dust exposure in schools in Taiyuan, China
(
- Contribution to journal › Article
-
Mark
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
(
- Contribution to journal › Article
-
Mark
Achieving asthma control in practice: Understanding the reasons for poor control
(
- Contribution to journal › Scientific review
-
Mark
Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN
(
- Contribution to journal › Scientific review
-
Mark
The Brussels Declaration: the need for change in asthma management
(
- Contribution to journal › Article
-
Mark
SAR studies of capsazepinoid bronchodilators 3: The thiourea part (coupling region) and the 2-(4-chlorophenyl)ethyl moiety (C-region).
(
- Contribution to journal › Article
- 2007
-
Mark
Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma
(
- Contribution to journal › Article